Drug Search Results
More Filters [+]


Alternative Names: lactobacillus-fermentum, lc-40, lc40, lc 40
Latest Update: 2024-05-14
Latest Update Note: PubMed Publication

Product Description

Lactobacillus fermentum CECT 5716, isolated from human milk, has immunomodulatory, anti-inflammatory, and anti-infectious properties, as revealed by several in vitro and in vivo assays, which suggests a strong potential as a probiotic strain.  (Sourced from: https://pubmed.ncbi.nlm.nih.gov/25661998/)

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Dominican Republic

Approved Indications: None

Known Adverse Events: None

Company: Universidad Complutense de Madrid
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Lactobacillus-fermentum

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases



Trial Status


Primary Completion Date

Probability of Success

Recent News Events